{{Rsnum
|rsid=10838681
|Gene=NR1H3
|Chromosome=11
|position=47253513
|Orientation=plus
|GMAF=0.4284
|Gene_s=NR1H3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 41.6 | 52.2
| HCB | 45.3 | 43.1 | 11.7
| JPT | 47.3 | 38.2 | 14.5
| YRI | 24.5 | 51.0 | 24.5
| ASW | 12.3 | 50.9 | 36.8
| CHB | 45.3 | 43.1 | 11.7
| CHD | 53.2 | 39.4 | 7.3
| GIH | 9.9 | 47.5 | 42.6
| LWK | 15.5 | 38.2 | 46.4
| MEX | 10.3 | 44.8 | 44.8
| MKK | 7.7 | 42.9 | 49.4
| TSI | 3.9 | 32.4 | 63.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22399527
|Trait=None
|Title=Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits.
|RiskAllele=G
|Pval=1E-9
|OR=0.0800
|ORtxt=None
|OA=1
}}

{{PMID|17357082|OA=1
}} Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}